IKF Pneumologie GmbH & Co. KG
Frankfurt, Germany
Allergist in Frankfurt, Hessen
Schaumainkai 100-103, 60596 Frankfurt am Main
About IKF Pneumologie GmbH & Co. KG
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
11
BioNTech SE
4
Pfizer
4
Hoffmann-La Roche
2
AbbVie
1
EpiEndo Pharmaceuticals
1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.
1
Johannes Gutenberg University Mainz
1
Verona Pharma plc
1
Clinical Trials at IKF Pneumologie GmbH & Co. KG
During the past decade, IKF Pneumologie GmbH & Co. KG conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 15 clinical trials were completed, i.e. on
average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma
2015-06-26
2017-03-09
Terminated
54
Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
2015-06-23
2018-02-02
Completed
214
Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD
2016-01-25
2016-06-14
Completed
120
Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
2012-02-16
2016-09-15
Completed
1,009
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
2016-04-13
2021-06-14
Completed
464
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "IKF Pneumologie GmbH & Co. KG" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "BioNTech SE" with 4 trials
sponsored, "Pfizer" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AbbVie"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IKF Pneumologie GmbH & Co. KG"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at IKF Pneumologie GmbH & Co. KG
According to Clinical.Site data, the most researched conditions in "IKF Pneumologie GmbH & Co. KG" are
"Pulmonary Disease, Chronic Obstructive" (5 trials), "Asthma" (3 trials), "COVID-19" (3 trials), "COPD" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "IKF Pneumologie GmbH & Co. KG" in a lesser frequency.
Clinical Trials Intervention Types at IKF Pneumologie GmbH & Co. KG
Most popular intervention types in "IKF Pneumologie GmbH & Co. KG" are "Drug" (21 trials), "Biological" (4 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "BNT162b2" (4 trials), "Empagliflozin" (2 trials), "Olodaterol" (2 trials) and "Tiotropium" (2 trials). Other intervention names were less common.
Clinical Trials Genders at IKF Pneumologie GmbH & Co. KG
The vast majority of trials in "IKF Pneumologie GmbH & Co. KG" are
26 trials for "All" genders.
Clinical Trials Status at IKF Pneumologie GmbH & Co. KG
Currently, there are NaN active trials in "IKF Pneumologie GmbH & Co. KG".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in IKF Pneumologie GmbH & Co. KG,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in IKF Pneumologie GmbH & Co. KG, 3 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of IKF Pneumologie GmbH & Co. KG
IKF Pneumologie GmbH & Co. KG has several departments that took part in Clinical trials: "IKF Pneumologie GmbH & Co. KG Am Standort IFS - Interdisziplinäres Facharztzentrum" - 3 trials, "IKF Pneumologie Mainz Helix Medical Excellence Center Mainz" - 2 trials
Departments List